Trial Profile
A Phase III, Randomized, Multicenter, Placebo-Controlled, Double-Blind Clinical Trial to Study the Efficacy and Safety of CyPat (Cyproterone Acetate [CA]) for the Treatment of Hot Flashes Following Surgical or Chemical Castration of Prostate Cancer Patients and Its Impact on the Quality of Life in These Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Sep 2014
Price :
$35
*
At a glance
- Drugs Cyproterone (Primary)
- Indications Hot flashes
- Focus Adverse reactions; Therapeutic Use
- Sponsors Barr Laboratories
- 19 Sep 2014 New trial record